{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:43Z","timestamp":1786990423522,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijcard.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T05:46:05Z","timestamp":1415079965000},"page":"847-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: Results from the ATHEROREMO-IVUS study"],"prefix":"10.1016","volume":"177","author":[{"given":"Linda C.","family":"Battes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Martijn","family":"Akkerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin M.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit M.","family":"Oemrawsingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanneke P.M.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Regar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Jan","family":"van Geuns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijcard.2014.11.001_bb0005","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.ijcard.2014.11.001_bb0010","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"Sabatine","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.11.001_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2014.08.013","article-title":"C-reactive Protein in Relation to Coronary Plaque Burden and Presence of High Risk Lesions on Intravascular Ultrasound and Cardiovascular Outcome: Results of the ATHEROREMO-IVUS Study","author":"Cheng","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2014.11.001_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejim.2006.07.031","article-title":"Acute phase proteins in patients with acute coronary syndrome: correlations with diagnosis, clinical features, and angiographic findings","volume":"18","author":"Brunetti","year":"2007","journal-title":"Eur. J. Int. Med."},{"issue":"22","key":"10.1016\/j.ijcard.2014.11.001_bb0025","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/01.CIR.0000017327.69909.FF","article-title":"Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men","volume":"105","author":"Engstrom","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2014.11.001_bb0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2174\/187152512803530298","article-title":"Acute phase proteins in acute coronary syndrome: an up-to-date","volume":"10","author":"Correale","year":"2012","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.ijcard.2014.11.001_bb0035","article-title":"Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study","author":"de Boer","year":"2013","journal-title":"EuroIntervention"},{"issue":"20","key":"10.1016\/j.ijcard.2014.11.001_bb0040","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/eurheartj\/ehq280","article-title":"Imaging of coronary atherosclerosis: intravascular ultrasound","volume":"31","author":"Garcia-Garcia","year":"2010","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2014.11.001_bb0045","first-page":"113","article-title":"Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation","volume":"3","author":"Nair","year":"2007","journal-title":"EuroIntervention"},{"issue":"23","key":"10.1016\/j.ijcard.2014.11.001_bb0050","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology","volume":"29","author":"Van de Werf","year":"2008","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcard.2014.11.001_bb0055","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2014.11.001_bb0060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","article-title":"Serum ferritin: past, present and future","volume":"1800","author":"Wang","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.ijcard.2014.11.001_bb0065","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood.V90.12.4979","article-title":"Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron","volume":"90","author":"Tran","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ijcard.2014.11.001_bb0070","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1161\/ATVBAHA.112.253088","article-title":"Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men","volume":"32","author":"Sung","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ijcard.2014.11.001_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2004.01.011","article-title":"Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations","volume":"174","author":"Braun","year":"2004","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.ijcard.2014.11.001_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1047-2797(00)00068-5","article-title":"Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study","volume":"10","author":"Sempos","year":"2000","journal-title":"Ann. Epidemiol."},{"issue":"12","key":"10.1016\/j.ijcard.2014.11.001_bb0085","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/oxfordjournals.eurheartj.a060440","article-title":"Serum ferritin and ceruloplasmin as coronary risk factors","volume":"15","author":"Manttari","year":"1994","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2014.11.001_bb0090","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1016\/j.ijcard.2013.07.095","article-title":"Serum ferritin deficiency and major adverse cardiovascular events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction without anemia","volume":"168","author":"Dominguez-Rodriguez","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2014.11.001_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mhj.2000.106646","article-title":"Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data","volume":"140","author":"Zacharski","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2014.11.001_bb0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1749-6632.1994.tb44342.x","article-title":"Alpha 2-macroglobulin: a ferritin-binding protein","volume":"737","author":"Massover","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.ijcard.2014.11.001_bb0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2012.09074.x","article-title":"PAI-1, progress in understanding the clinical problem and its aetiology","volume":"157","author":"Iwaki","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"15","key":"10.1016\/j.ijcard.2014.11.001_bb0110","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1074\/jbc.M008503200","article-title":"Alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells","volume":"276","author":"Ikari","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijcard.2014.11.001_bb0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcla.20012","article-title":"Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort","volume":"18","author":"Ritchie","year":"2004","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.ijcard.2014.11.001_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2005.07.004","article-title":"Cardiac isoform of alpha-2 macroglobulin\u2014a new biomarker for myocardial infarcted diabetic patients","volume":"186","author":"Annapoorani","year":"2006","journal-title":"Atherosclerosis"},{"issue":"1\u20132","key":"10.1016\/j.ijcard.2014.11.001_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11010-010-0702-4","article-title":"Role of cardiac isoform of alpha-2 macroglobulin in diabetic myocardium","volume":"350","author":"Soman","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.ijcard.2014.11.001_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.hlc.2009.10.005","article-title":"Cardiac isoform of alpha 2 macroglobulin and its reliability as a cardiac marker in HIV patients","volume":"19","author":"Subbiah","year":"2010","journal-title":"Heart Lung Circ."},{"issue":"15","key":"10.1016\/j.ijcard.2014.11.001_bb0135","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/01.aids.0000247122.97079.71","article-title":"Cardiac isoform of alpha 2 macroglobulin, an early diagnostic marker for cardiac manifestations in AIDS patients","volume":"20","author":"Ramasamy","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ijcard.2014.11.001_bb0140","first-page":"984","article-title":"The \u2018PAI-1 paradox\u2019 in vascular remodeling","volume":"100","author":"Diebold","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijcard.2014.11.001_bb0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0735-1097(87)80373-X","article-title":"Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations","volume":"9","author":"Mehta","year":"1987","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2014.11.001_bb0150","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.ijcard.2014.11.001_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00048.2003","article-title":"Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture","volume":"85","author":"Newby","year":"2005","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.ijcard.2014.11.001_bb0160","doi-asserted-by":"crossref","first-page":"e003725","DOI":"10.1136\/bmjopen-2013-003725","article-title":"Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study","volume":"3","author":"Iacoviello","year":"2013","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ijcard.2014.11.001_bb0165","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/01.CIR.94.9.2052","article-title":"Impaired fibrinolysis and the risk for coronary heart disease","volume":"94","author":"Lijnen","year":"1996","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ijcard.2014.11.001_bb0170","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2174\/138945011797635803","article-title":"Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease","volume":"12","author":"Ploplis","year":"2011","journal-title":"Curr. Drug Targets"},{"issue":"9","key":"10.1016\/j.ijcard.2014.11.001_bb0175","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/092986708783955455","article-title":"Fibrinolysis: the key to new pathogenetic mechanisms","volume":"15","author":"Zorio","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijcard.2014.11.001_bb0180","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.thromres.2012.06.015","article-title":"Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis","volume":"130","author":"Gong","year":"2012","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.ijcard.2014.11.001_bb0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/01.CIR.0000049642.20484.5D","article-title":"Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study","volume":"107","author":"Dahl","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2014.11.001_bb0190","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.ATV.0000065196.61663.8D","article-title":"Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene","volume":"23","author":"Talmud","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.ijcard.2014.11.001_bb0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1538-7836.2010.04172.x","article-title":"Complement in atherosclerosis: friend or foe?","volume":"9","author":"Speidl","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijcard.2014.11.001_bb0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2013.07.008","article-title":"Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events","volume":"230","author":"Ijas","year":"2013","journal-title":"Atherosclerosis"},{"issue":"21","key":"10.1016\/j.ijcard.2014.11.001_bb0205","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2010.02.026","article-title":"Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome","volume":"55","author":"Nicholls","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2014.11.001_bb0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/eurheartj\/eht484","article-title":"In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study","volume":"35","author":"Cheng","year":"2014","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2014.11.001_bb0215","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcmg.2011.01.019","article-title":"Are our tools for the identification of TCFA ready and do we know them?","volume":"4","author":"Virmani","year":"2011","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314021433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314021433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T07:55:45Z","timestamp":1598428545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314021433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0167527314021433"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.001","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: Results from the ATHEROREMO-IVUS study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}